

Results for the Second Quarter and First Half 2025
Posted on
August 20, 2025
by Medistim
Currency neutral sales of own products were up 18.7 % for the quarter and 25.4 % for the first half. Strong currency neutral growth for the quarter in AMERICAS and APAC, up 32.9 % and 22.9 % respectively. EMEA down 3.6 %, yet growing 8.1% in the first half.
Third-party distributor sales in Scandinavia increased 3.3 % for the quarter and 21.4 % for the first half year. Operating profit (EBIT) grew by 31.2 % for the quarter and ended at MNOK 54.1, resulting in 32.0 % EBIT margin (MNOK 41.2, 28.5 % margin).
First half operating profit grew 54.5 % ending at a record MNOK 113.3, and 32.3 % EBIT margin (MNOK 73.3, 26.3 % margin).